{{Cite journal| doi = 10.1093/ofid/ofv111| volume = 2| issue = 3| pages = –111| last1 = Mwanga-Amumpaire| first1 = J.| last2 = Carroll| first2 = R.| last3 = Baudin| first3 = E.| last4 = Kemigisha| first4 = E.| last5 = Nampijja| first5 = D.| last6 = Mworozi| first6 = K.| last7 = Santorino| first7 = D.| last8 = Nyehangane| first8 = D.| last9 = Nathan| first9 = D. I.| last10 = Debeaudrap| first10 = Pierre| last11 = Etard| first11 = Jean-François| last12 = Feelisch| first12 = M.| last13 = Fernandez| first13 = B. O.| last14 = Berssenbrugge| first14 = A.| last15 = Bangsberg| first15 = D.| last16 = Bloch| first16 = K. D.| last17 = Boum| first17 = Y.| last18 = Zapol| first18 = W. M.| title = Inhaled Nitric Oxide as an Adjunctive Treatment for Cerebral Malaria in Children: A Phase II Randomized Open-Label Clinical Trial| journal = Open Forum Infect Dis| date = 2015-09}}